The HemOnc Pulse

Amer Zeidan, MBBS, MHS, on the Evolution of AML Classification, Treatment

Apr 6, 2023

26:55

Creator website

AI Chapters

Episode notes

Introduction

2min

Acute Myeloid Leukemia

3min

The Importance of Genetics in Genetics

3min

How to Diagnose Acute Myeloid Leukemia in a 45 Year Old Person

5min

The Different Approaches to Leukemia Management

2min

IDH1 and Venetoclax in a Younger Patient Population

2min

The Importance of Age in Transplantation

2min

The Importance of MRD in Non-Acute Promolocytic Leukemia

4min

The Future of Morphology in APL and CML

3min

In this episode of The HemOnc Pulse, Amer Zeidan, MBBS, MHS, of Yale, discusses the impact of AML classification updates, the practical implications of testing for genetic alterations, and how patient characteristics inform his approach to treating AML, with host Chadi Nabhan, MD, MBA, FACP.